inotersen (tegsedi) Report issue

Biologics Nucleic acid Orphan Drug FDA Approved FDA Fast Track FDA Priority Review FDA

Active Ingredient History

  • Now
Inotersen, sold under the brand name Tegsedi, is a 2'-O-(2-methoxyethyl) (2'-MOE) antisense oligonucleotide medication used for the treatment of nerve damage in adults with hereditary transthyretin-mediated amyloidosis. The sequence is TCTTG GTTACATGAA ATCCC, where C is methylated C, and the first and third section are MOE-modified.   Wikipedia

More Chemistry

Drug Pricing (per unit)

United States

$6452.9750 - $8650.0000
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

gsk 299872 | inotersen sodium | isis 420915


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue